On behalf of the French Development Agency, the European Development Bank, and the European Union Delegation in Dakar, CARED conducted in May 2024 a comprehensive assessment on the readiness of the vaccine manufacturing facilities at the Institute Pasteur Dakar, Senegal. This evaluation focused on ensuring compliance with Good Manufacturing Practices (GMP) standards and identifying opportunities for optimization. By addressing critical gaps in manufacturing processes, this initiative positions Senegal as a key player in vaccine production for the African continent, contributing to regional self-sufficiency for lifesaving vaccines and strengthening Africa’s vaccine manufacturing ecosystem.